All In Biotech

Drug Trial Radar · NCT05254574

Sustained Acoustic Medicine for Osteoarthritis Pain

Last checked: Nov 20, 2026Latest source record: Feb 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Feb 14, 2022

Primary completion

May 1, 2026

Study completion May 31, 2026

Sponsor

Lead sponsor
ZetrOZ, Inc.Industry
Sponsor type
Industry
First posted
Feb 24, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 35 years, up to 85 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare Sustained Acoustic Medicine treatment to topical pain relief gel for the symptomatic management of osteoarthritis. The study will measure pain and function scores for patients undergoing treatment.

Conditions

  • Osteoarthritis

Interventions

  • Sustained Acoustic Device with 2.5% Diclofenac PatchDevice

    Patients apply the SAM Ultrasonic Diathermy Device daily for 1-4 hours of continuous therapeutic ultrasound at 3 megahertz(MHz) frequency and 0.132 Watts/cm@ with 2.5% Diclofenac patches.

  • 2.5% Diclofenac PatchesDrug

    Topical pain relief-gel worn for 4 hours at least 5 days a week via SAM patch.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Pain Units on a Scale (0-10) 0 Being Least, 10 Being Worst Pain From BaselineTime frame: Through study completion, average of 8 weeks
  2. Change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)Time frame: Time Frame: Through study completion, average of 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • James A Haley Veterans Hospital

    Tampa, Florida · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.